Urvinder Kaur Sardarni

Urvinder Kaur Sardarni

Auto-generated profile, based on publicly available information

Urvinder Kaur Sardarni

Laboratory of AIDS Research and Immunology, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2024 in ACS Omega
Verified
Journal Article
Open access
AVAnjali Verma
Anjali Verma
TBTannu Bhagchandani
Tannu Bhagchandani
ARAnkita Rai
Ankita Rai
USUrvinder Kaur Sardarni
Urvinder Kaur Sardarni
Neel Sarovar BhaveshNeel Sarovar Bhavesh
Neel Sarovar Bhavesh
RTRavi Tandon
Ravi Tandon
The microbiome is an integral part of the human gut, and it plays a crucial role in the development of the immune system and homeostasis. Apart from the gut microbiome, the airway microbial community also forms a distinct and crucial part of the human microbiota. Furthermore, several studies indicate the existence of communication between the gut microbiome and their metabolites with the lung airways, called “gut–lung axis”. Perturbations in gut microbiota composition, termed dysbiosis, can have acute and chronic effects on the pathophysiology of lung diseases. Microbes and their metabolites in lung stimulate various innate immune pathways, which modulate the expression of the inflammatory genes in pulmonary leukocytes. For instance, gut microbiota-derived metabolites such as short-chain fatty acids can suppress lung inflammation through the activation of G protein-coupled receptors (free fatty acid receptors) and can also inhibit histone deacetylase, which in turn influences the severity of acute and chronic respiratory diseases. Thus, modulation of the gut microbiome composition through probiotic/prebiotic usage and fecal microbiota transplantation can lead to alterations in lung homeostasis and immunity. The resulting manipulation of immune cells function through microbiota and their key metabolites paves the way for the development of novel therapeutic strategies in improving the lung health of individuals affected with various lung diseases including SARS-CoV-2. This review will shed light upon the mechanistic aspect of immune system programming through gut and lung microbiota and exploration of the relationship between gut–lung microbiome and also highlight the therapeutic potential of gut microbiota-derived metabolites in the management of respiratory diseases.

8 November 2023 in Heliyon
Verified
Journal Article
Open access
BOBolaji F Oyeyemi
Bolaji F Oyeyemi
UKUrvinder S. Kaur
Urvinder S. Kaur
APAmit Paramraj
Amit Paramraj
CHChintamani
Chintamani
RTRavi Tandon
Ravi Tandon
Neel Sarovar BhaveshNeel Sarovar Bhavesh
Neel Sarovar Bhavesh
Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer and accounts for about 95% of all head and neck cancers with high mortality, usually at a late stage. Dysbiosis in the oral microbiome can lead to chronic inflammatory responses and may predispose to the development and progression of OSCC. Tobacco abuse plays an essential role in oral microbiome dysregulation and OSCC pathogenesis. We used 16S rRNA gene amplicon next-generation sequencing to examine microbial signatures unique to saliva from OSCC patients, tobacco abusers (TA) and controls (n = 10 for each group) to elucidate oral microbiome changes associated with tobacco abuse and OSCC. Overall, the oral microbiome compositions of class Betaproteobacteria and Epsilonproteobacteria, order Neisseriales, Burkholderiales and Campylobacterales, family Burkholderiaceae and Campylobacteraceae and genera Campylobacter and Leptotrichia revealed significant differences among OSCC patients, TA and control. Our preliminary pilot study not only serves as a basis for future studies with large sample size but also gives an indication of microbiome-based potential non-invasive biomarkers for early screening and monitoring of oral carcinogenesis transition due to tobacco abuse.

23 January 2020 in Current Genomics
Verified
Journal Article
Closed access
PDF file
VNVidhya Natarajan
Vidhya Natarajan
PMPreeti Moar
Preeti Moar
UKUrvinder S. Kaur
Urvinder S. Kaur
VVVimala Venkatesh
Vimala Venkatesh
AAAbhishek A0bhishek
Abhishek A0bhishek
RTRavi Tandon
Ravi Tandon
Background: Helicobacter pylori are gram-negative bacteria, which colonize the human stomach. More than 50% of the world’s population is infected by H. pylori. Based on the high prevalence of H. pylori, it is very likely that HIV and H. pylori infection may coexist. However, the molecular events that occur during HIV-H. pylori co-infection remain unclear. Latent HIV reservoirs are the major obstacle in HIV cure despite effective therapy. Here, we explored the effect of H. pylori stimulation on latently HIV-infected monocytic cell line U1. Method: High throughput RNA-Seq using Illumina platform was performed to analyse the change in transcriptome between unstimulated and H. pylori-stimulated latently HIV-infected U1 cells. Transcriptome analysis identified potential genes and pathways involved in the reversal of HIV latency using bioinformatic tools that were validated by real-time PCR. Results: H. pylori stimulation increased the expression of HIV-1 Gag, both at transcription (p<0.001) and protein level. H. pylori stimulation also increased the expression of proinflammatory cytokines IL-1β, CXCL8 and CXCL10 (p<0.0001). Heat-killed H. pylori retained their ability to induce HIV transcription. RNA-Seq analysis revealed 197 significantly upregulated and 101 significantly downregulated genes in H. pylori-stimulated U1 cells. IL-1β and CXCL8 were found to be significantly upregulated using transcriptome analysis, which was consistent with real-time PCR data. Conclusion: H. pylori reactivate HIV-1 in latently infected monocytes with the upregulation of IL-1β and CXCL8, which are prominent cytokines involved in the majority of inflammatory pathways. Our results warrant future in vivo studies elucidating the effect of H. pylori in HIV latency and pathogenesis.

1 May 2026 in Cancer Research Communications
Verified
Journal Article
Open access
USUrvinder Kaur Sardarni
Urvinder Kaur Sardarni
EFErika Y. Faraoni
Erika Y. Faraoni
AWAlyssa Morgan Waller
Alyssa Morgan Waller
LSLincoln N. Strickland
Lincoln N. Strickland
BOBaylee O’BRien
Baylee O’BRien
JBJennifer M. Bailey-Lundberg
Jennifer M. Bailey-Lundberg
Dietary macronutrient composition has emerged as a key modulator of pancreatic tumorigenesis, yet the impact of lipid-rich diets, particularly ketogenic diets (KD), on the earliest stages of pancreatic cancer development remains unclear. To investigate how dietary lipids shape the initiation and progression of Kras-driven neoplasia, we examined the effects of a low-fat diet (LFD), high-fat diet (HFD), and KD in the Ptf1aCreERT2;KrasG12V (AcinarKrasG12V) mouse model. KD-fed mice showed the shortest survival (median 26 ± 7 days) compared with the standard diet (SD, 87 ± 29; P = 0.02) and LFD (57 ± 27; P = 0.02), whereas HFD-fed mice also exhibited reduced survival relative to SD (35 ± 25; P = 0.05). KD feeding was associated with severe glucose intolerance and elevated circulating β-hydroxybutyrate levels. Histologically, KD-fed AcinarKrasG12V mice developed invasive, sarcomatoid-like pancreatic ductal adenocarcinoma (PDAC), whereas HFD-fed mice showed increased poorly differentiated PDAC; in both groups, these aggressive tumors were associated with extensive fibrosis and increased stromal CD39 expression relative to tumor compartments. Proteomic analysis demonstrated activation of the PI3K–Akt–mTOR and EGFR signaling pathways in tumors from KD- and HFD-fed AcinarKrasG12V mice. Serum cytokine/chemokine profiling revealed a proinflammatory and proangiogenic milieu in KD-fed AcinarKrasG12V mice. Collectively, these results suggest that dietary lipid enrichment prior to oncogenic Kras activation is associated with accelerated early pancreatic neoplasia and a microenvironment conducive to tumor progression. These findings underscore the need for careful consideration of KD use in individuals at elevated risk for pancreatic cancer. Significance: This article evaluates the impact of KDs and HFDs prior to oncogenic Kras activation in the AcinarKrasG12V model. These findings reveal that lipid-rich diets accelerate PDAC progression and have important implications for dietary recommendations in individuals at elevated pancreatic cancer risk.

8 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LSLincoln N. Strickland
Lincoln N. Strickland
MDMacKenzie Demmel
MacKenzie Demmel
WLWendao Liu
Wendao Liu
AWAlyssa Morgan Waller
Alyssa Morgan Waller
SDShwetapadma Dash
Shwetapadma Dash
JBJennifer M. Bailey-Lundberg
Jennifer M. Bailey-Lundberg
Thermal ablation is increasingly used for local control of pancreatic ductal adenocarcinoma (PDAC), but its capacity to induce systemic antitumor immunity and the mechanisms limiting this response remain incompletely defined. Using a bilateral LSL-Kras G12D/+; LSL-Trp53 R172H/+ ; Pdx1-Cre (KPC) flank tumor model, we show serial radiofrequency ablation (RFA) enhances local tumor control and induces a robust abscopal response. This effect was associated with increased activation of CD8⁺ T cells and natural killer cells, and was abrogated by CD8⁺ T cell depletion. Single-cell RNA sequencing revealed expansion of cytotoxic immune programs alongside induction of a CSF1R-driven myeloid response consistent with adaptive immune resistance. Although combinatorial blockade of PD-L1 and CD73 augmented systemic antitumor responses, and the addition of CSF1R inhibition in this context further enhanced both local and distant tumor control. These findings identify a CSF1R-dependent myeloid resistance program which constrains ablation-induced systemic immunity and demonstrate that rational combination immunotherapy can potentiate the systemic efficacy of tumor ablation in PDAC. STATEMENT OF TRANSLATIONAL RELEVANCE: Radiofrequency ablation is a local thermal therapy that induces tumor destruction and modulation of the tumor microenvironment used for treatment of many solid tumors, including pancreatic cancer. Serial thermal ablations induce a CD8+ T cells and NK cell antitumor immunological response; however, Nt5e (CD73) is increased in tumor cells, PD-1 is increased in CD8+ T cells, and serial ablations increase a CSF1R+ macrophage cluster in ablated tumors. Combinational targeting of CD73, PD-L1, and CSF1R alleviates CSF1R-dependent therapeutic resistance and enhances local and systemic tumor control. This study identifies targetable countervailing mechanisms to local ablation therapy and provides a rationale for combinatorial strategies integrating serial tumor ablation with systemic immunomodulatory agents. Future prospective studies should evaluate the influence of timing, dosage, and sequence of ablation on immune priming to improve clinical interventions in pancreatic cancer.

17 June 2026
Verified
Other
Open access
USUrvinder Kaur Sardarni
Urvinder Kaur Sardarni
EFErika Y. Faraoni
Erika Y. Faraoni
AWAlyssa Morgan Waller
Alyssa Morgan Waller
LSLincoln N. Strickland
Lincoln N. Strickland
BOBaylee O’BRien
Baylee O’BRien
JBJennifer M. Bailey-Lundberg
Jennifer M. Bailey-Lundberg
KD is associated with systemic inflammatory and angiogenic cytokine responses in WT and AcinarKrasG12V mice. A, Heatmap depicting serum cytokine and chemokine expression across WT and AcinarKrasG12V mice fed SD or KD. Cytokines/chemokines are hierarchically clustered by expression pattern. Red indicates higher abundance, whereas blue indicates lower abundance. B, Bar graph showing the mean pixel density of cytokines/chemokines in serum from SD-fed WT, KD-fed WT, SD-fed AcinarKrasG12V, and KD-fed AcinarKrasG12V mice. One biological replicate was analyzed per group.